ALTIMMUNE, INC. Retained Earnings
ALTIMMUNE, INC. (ALT) had Retained Earnings of -$694.87 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$694.87M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$672.05M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$649.48M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$622.13M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$694.87M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$672.05M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$649.48M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$622.13M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$603.11M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$580.97M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$561.39M 10-K · filed 2026-03-06 | |
| 2024-09-30 | -$538.21M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$515.37M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$490.73M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$466.33M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$434.69M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$414.02M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$397.96M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$377.88M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$356.22M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$332.71M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$312.60M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$293.17M 10-K · filed 2023-02-28 | -$293.17M 10-K · filed 2022-03-15 |
| 2021-09-30 | -$269.28M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$235.77M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$210.94M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$186.42M 10-K · filed 2022-03-15 | |
| 2020-09-30 | -$175.80M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$158.03M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$141.26M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$137.38M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$133.28M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$122.34M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$118.95M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$116.86M 10-K · filed 2020-03-27 | |
| 2018-09-30 | -$92.35M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$90.00M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$80.86M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$77.68M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$68.85M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$38.95M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$32.07M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$31.26M 10-K · filed 2018-04-02 | -$29.87M 10-K · filed 2017-03-14 |
| 2016-09-30 | -$107.67M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$216.91M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$224.95M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$223.72M 10-K · filed 2017-03-14 | |
| 2015-09-30 | -$222.49M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$221.16M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$218.82M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$220.28M 10-K · filed 2016-03-11 | |
| 2014-09-30 | -$217.65M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$213.03M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | -$212.59M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$210.33M 10-K · filed 2015-03-11 | |
| 2013-09-30 | -$205.90M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$201.96M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$200.72M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | -$198.61M 10-K · filed 2014-03-11 | |
| 2012-09-30 | -$197.34M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | -$197.13M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$196.37M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$193.69M 10-K · filed 2013-03-14 | |
| 2011-09-30 | -$194.44M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$194.41M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | -$189.89M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |